Life Sciences Tools and Services
Company Overview of Agilux Laboratories, Inc.
Agilux Laboratories, Inc., a contract research organization, offers a range of services supporting discovery, pre-clinical, and clinical services. It provides a range of drug metabolism and pharmacokinetic (DMPK) Services for biotech and pharmaceutical industries. The company’s services include discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and Immunoassays (biomarkers) services. Agilux Laboratories was founded in 2007 and is based in Worcester, Massachusetts.
One Innovation Drive
Worcester, MA 01605
Founded in 2007
Key Executives for Agilux Laboratories, Inc.
Co-Founder and Vice President of Sales & Marketing
Senior Director of Operations and IT
Head of GLP Bioanalysis - Pharmaceutical Development Services
Compensation as of Fiscal Year 2014.
Agilux Laboratories, Inc. Key Developments
Agilux Laboratories, Inc. Appoints Richard M. LeLacheur as Head of GLP Bioanalysis for Bioanalytical Operations
Apr 9 14
Agilux Laboratories, Inc. announced that it has appointed Richard M. LeLacheur, Ph.D. to Head of GLP Bioanalysis for its pharmaceutical development services. Rich joined Agilux in early 2012 as Senior Director, Bioanalytical Operations and has also served as a member of its senior management team since that time. In his new role, Rich will be directly responsible for driving the scientific, regulatory and operational processes and improvements within its GLP bioanalytical labs.
Agilux Laboratories Undergoes Space Expansion of in Vivo Pharmacokinetics Services
Dec 5 13
Agilux Laboratories undergone a significant space expansion of its in vivo pharmacokinetics services. The company has undergone space expansion to support customer's demands and increase service requirements. The space expansion will help Agilux to significantly increase its capacity and volume.
Agilux Laboratories Appoints Geeta Sharma as Senior Director, Pharmacology
Sep 10 13
Agilux Laboratories announced that Geeta Sharma, Ph.D. has joined the Agilux team as Senior Director, Pharmacology. In this role, Dr. Sharma will lead the Pharmacology group and will initially be focused on developing and launching non-GLP discovery oncology services. Dr. Sharma will also serve as a member of the senior management team. Dr. Sharma has more than fifteen years of experience in Drug Discovery in multiple therapeutic areas including oncology, infectious diseases, metabolic disorders, and inflammation. She has led discovery programs that have successfully translated to clinical candidates. She has published more than fiftten research articles and has contributed to eleven patents. Most recently, Dr. Sharma was Senior Director, Pharmacology at Forma Therapeutics at their Singapore location. Prior to this, Dr. Sharma has held roles of increasing responsibility at Combinatorx Singapore and Ranbaxy Laboratories, LTD.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|